Seeking Alpha

IMUC
  ImmunoCellular Therapeutics, Ltd. - NYSEMKT

10/31/2014, 4:10 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
IMUC vs. ETF Alternatives
Company Description
ImmunoCellular Therapeutics Limited is a clinical-stage biotechnology company that develops immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.